Evidence map›Paper›PMID 17226071›Full record

ArticleDigestive diseases and sciences2007

Effect of different cyclooxygenase inhibitors on gastric adaptive cytoprotection induced by 20% ethanol.

Alessandra Gambero, Marta Maróstica, Tagliane Liza Becker, José Pedrazzoli

Abstract read
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Alessandra GamberoClinical Pharmacology and Gastroenterology Unit, São Francisco University Medical School, Av São Francisco de Assis 218, Bragança Paulista, 12916-900, SP, Brazil. alessandragambero@saofrancisco.edu.br
Marta Maróstica
Tagliane Liza Becker
José Pedrazzoli
Universidade São Francisco · BRSanta Casa da Misericórdia de Bragança Paulista · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we evaluated the effect of two different dosages of therapeutically prescribed nonsteroidal anti-inflammatory drugs (NSAIDs), ibuprofen, diclofenac, nimesulide, meloxicam, and celecoxib (ED80 for COX-1 and COX-2) on normal gastric mucosa and mucosa, previously exposed to 20% ethanol. At COX-2-inhibiting dosages, the NSAIDs tested were nonulcerogenic, and the same response profile was observed in "adapted" stomachs. Interestingly, low doses of nimesulide and celecoxib increase the levels of Prostaglandin E(2) and COX-2, and protect against subsequent 100% ethanol exposition, suggesting that these drugs may act as "mild irritants" to gastric mucosa. The ulcerogenic response to NSAIDs was prevented by the previous 20% ethanol exposition, probably the result of nitric oxide synthesis, because PGE(2) levels in gastric mucosa were reduced by these agents and a concomitant nitric oxide blockade reversed this protection.

Indexed as

AnimalsCelecoxibCyclooxygenase 1Cyclooxygenase 2Cyclooxygenase InhibitorsCytoprotectionDiclofenacDinoprostoneDose-Response Relationship, DrugEnzyme InhibitorsEthanolGastric AcidGastric MucosaIbuprofenIrritantsMaleCelecoxibCyclooxygenase 1Cyclooxygenase 2Cyclooxygenase InhibitorsDiclofenacDinoprostoneEnzyme InhibitorsEthanolIbuprofenIrritantsMeloxicamMembrane ProteinsNG-Nitroarginine Methyl EsternimesulideNitric OxideNitric Oxide SynthasePtgs1 protein, ratPtgs2 protein, ratPyrazolesSulfonamidesThiazinesThiazoles

Identifiers

PMID17226071
OpenAlexW2052023006

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.